Biotech by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Biogen has the lowest figure of the 19 biotech ranked by P/S ratio, at 3.7, followed by Qiagen (4.9) and Neurocrine Biosciences (5.9). Figures as of 18 Nov 2026, 13:57 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
Lowest
Biogen3.7
Median
14.0
Combined market value
PLN 3.41T
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

Biotech by P/S ratio
#CompanyP/S ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care3.7PLN 149BPLN 1,007.77 0.34% down 49% up United States
2QiagenQGEN · Health Care4.9PLN 41.3BPLN 199.92 0.12% down 12% up Netherlands
3Neurocrine BiosciencesNBIX · Health Care5.9PLN 67.5BPLN 666.73 0.37% up 20% up United States
4BioNTechBNTX · Health Care6.6PLN 84.5BPLN 341.00 0.47% down 16% down Germany
5AmgenAMGN · Health Care6.7PLN 995.4BPLN 1,840.15 0.95% down 34% up United States
6Gilead SciencesGILD · Health Care7.2PLN 848.6BPLN 684.17 1.60% up 33% up United States
7ExelixisEXEL · Health Care7.2PLN 67.2BPLN 275.26 2.09% up 63% up United States
8Halozyme TherapeuticsHALO · Health Care7.8PLN 44BPLN 385.65 0.55% down 37% up United States
9Bio-TechneTECH · Health Care9.4PLN 45.8BPLN 291.86 0.22% down 26% up United States
10RepligenRGEN · Health Care14.0PLN 41.7BPLN 651.70 0.37% down 5% up United States
11argenxARGX · Health Care14.4PLN 239.4BPLN 3,807.51 0.36% down 4% up Belgium
12Adaptive BiotechnologiesADPT · Health Care16.7PLN 18.5BPLN 114.48 2.22% up 88% up United States
13Twist BioscienceTWST · Health Care20.3PLN 30.7BPLN 450.06 6.63% up 340% up United States
14Krystal BiotechKRYS · Health Care22.7PLN 35.6BPLN 1,199.69 0.22% up 46% up United States
15ModernaMRNA · Health Care43.0PLN 336.2BPLN 831.01 3.93% down 755% up United States
16ImmunityBioIBRX · Health Care58.8PLN 26.8BPLN 25.16 4.68% up 193% up United States
17Kymera TherapeuticsKYMR · Health Care265PLN 41.7BPLN 488.32 3.44% down 87% up United States
18CRISPR TherapeuticsCRSP · Health Care1110PLN 15.6BPLN 161.34 0.54% down 21% down Switzerland
19CG OncologyCGON · Health Care1745PLN 28.3BPLN 317.21 6.89% down 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0184 PLN). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech have the lowest P/S ratio?

Biogen (3.7), Qiagen (4.9) and Neurocrine Biosciences (5.9) have the lowest P/S ratio of the 19 biotech ranked here as of 18 Nov 2026, 13:57 UTC.

How many biotech are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech worth together?

The 19 biotech ranked by P/S ratio have a combined market value of PLN 3.41T as of 18 Nov 2026, 13:57 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.